Ubrelvy 100 MG tablet UD 10S
Ended Awarded
- Contract number
- SPE2DB26FTH21
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,089
Award facts
- Contract value 100% obligated
- $17,088.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $17,088.89 firm fixed-price delivery order for UBRELVY 100 mg tablets (10-count unit dose packages) on October 29, 2025, with an ultimate completion date of October 30, 2025. This non-set-aside contract represents a small-value pharmaceutical delivery executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026. The delivery order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as a major pharmaceutical distributor and healthcare solutions provider.
AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems worldwide. UBRELVY, a migraine treatment medication, exemplifies the company's extensive portfolio of specialty pharmaceuticals delivered through competitive federal contracts. As the prime contractor on this delivery order, AmerisourceBergen leverages its comprehensive DLA Troop Support Medical contract vehicle to fulfill diverse pharmaceutical needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FTH21?
SPE2DB26FTH21 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FTH21 worth?
The government has obligated $17,089 on SPE2DB26FTH21.
Is contract SPE2DB26FTH21 an order under another contract?
Yes. SPE2DB26FTH21 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB26FTH21 competed?
The extent of competition for SPE2DB26FTH21 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award